YahooOctober 22, 2026 at 12:45 PM NY5 Days Ago
Avalo Therapeutics Abdakibart Potential Intact After AbbVie Data, Wedbush Says
Avalo Therapeutics' (AVTX) abdakibart remains promising for hidradenitis suppurativa, with phase 2 r
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo